Satellos Bioscience Stock Quote MSCL - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.53

Bid

0.52

Ask

0.56

Volume

0.00 Day's Range 0.00

0.38 52 Week Range 0.80

Market Cap

59.78M

Previous Close

0.53

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

52,530

Shares Outstanding

112,792,000

Dividend Yield

PE Ratio

-3.76

Earnings Per Share (EPS)

-0.14

Revenue

Net Profit

-15.89M

Sector

Coml Physical, Biologcl Resh

Industry

Pharmaceutical Preparations

Website

www.satellos.com

Headquarters

Toronto, Ontario, Can

Founded

2007

Satellos Bioscience Inc is listed in the Coml Physical, Biologcl Resh sector of the Toronto Stock Exchange with ticker MSCL. The last closing price for Satellos Bioscience was $0.53. Over the last year, Satellos Bioscience shares have traded in a share price range of $ 0.38 to $ 0.80.

Satellos Bioscience currently has 112,792,000 shares outstanding. The market capitalization of Satellos Bioscience is $59.78 million. Satellos Bioscience has a price to earnings ratio (PE ratio) of -3.76.

Satellos Presents Preliminary Data Showing Muscle Repair and Regeneration from SAT-3247 Treatment in Canine Model of Duchenne Muscular Dystrophy (“DMD”)

–SAT-3247 treatment improved muscle repair and regeneration in canine model of DMD – SAT-3247 treatment also improved muscle force in this canine model of DMD – Satellos remains on track to...

Satellos Announces Presentation at Parent Project Muscular Dystrophy (PPMD) 30th Annual Conference

– Frank Gleeson, Satellos CEO, to participate in a panel discussion titled "Research Row: PPMD Moving the Needle" on June 29, 2024 – Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX:...

Satellos Announces Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy

Satellos expects to begin first-in-human clinical trials mid-year for SAT-3247, an oral small molecule drug candidate in development as a novel regenerative medicine approach to treating DMD...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.53	0.56	0.51	33581	0.53013095	CS
4	0.02	3.92156862745	0.51	0.64	0.5	70899	0.55083973	CS
12	0.03	6	0.5	0.64	0.38	52530	0.50530258	CS
26	-0.09	-14.5161290323	0.62	0.8	0.38	65468	0.54816942	CS
52	-0.09	-14.5161290323	0.62	0.8	0.38	65468	0.54816942	CS
156	-0.09	-14.5161290323	0.62	0.8	0.38	65468	0.54816942	CS
260	-0.09	-14.5161290323	0.62	0.8	0.38	65468	0.54816942	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VVPRVivoPower International PLC	$ 3.24 (116.00%)	14.94M
ZCARZoomcar Holdings Inc	$ 0.235 (72.04%)	49.68M
CNSPCNS Pharmaceuticals Inc	$ 2.07 (64.29%)	549.77k
CBRGChain Bridge I	$ 17.88 (57.26%)	129
DOYUDouYu International Holdings Ltd	$ 16.73 (32.88%)	982.81k
SHPWShapeways Holdings Inc	$ 0.3749 (-46.90%)	114.61k
TOIIWOncology Institute Inc	$ 0.0185 (-27.45%)	1
RPAYRepay Holdings Corporation	$ 8.08 (-20.86%)	34
NPCENeuropace Inc	$ 5.76 (-20.33%)	192
STISolidion Technology Inc	$ 0.395 (-16.26%)	651.76k
ZCARZoomcar Holdings Inc	$ 0.235 (72.04%)	49.68M
MAXNMaxeon Solar Technologies Ltd	$ 0.1975 (9.78%)	34.66M
VVPRVivoPower International PLC	$ 3.24 (116.00%)	14.94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 12.89 (4.04%)	11.86M
SMXSMX Security Matters Public Company	$ 0.1409 (20.12%)	10.77M